BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7481552)

  • 1. Hyperoncotic dextran and systemic aprotinin in necrotizing rodent pancreatitis.
    Huch K; Schmidt J; Schratt W; Sinn HP; Buhr H; Herfarth C; Klar E
    Scand J Gastroenterol; 1995 Aug; 30(8):812-6. PubMed ID: 7481552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperoncotic ultrahigh molecular weight dextran solutions reduce trypsinogen activation, prevent acinar necrosis, and lower mortality in rodent pancreatitis.
    Schmidt J; Ferńandez-del Castillo C; Rattner DW; Lewandrowski KB; Messmer K; Warshaw AL
    Am J Surg; 1993 Jan; 165(1):40-4; discussion 45. PubMed ID: 7678189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of various dextrans after delayed therapy in necrotizing pancreatitis of the rat.
    Schmidt J; Huch K; Mithöfer K; Hotz HG; Sinn HP; Buhr HJ; Warshaw AL; Herfarth C; Klar E
    Intensive Care Med; 1996 Nov; 22(11):1207-13. PubMed ID: 9120115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isovolemic hemodilution with dextran prevents contrast medium induced impairment of pancreatic microcirculation in necrotizing pancreatitis of the rat.
    Hotz HG; Schmidt J; Ryschich EW; Foitzik T; Buhr HJ; Warshaw AL; Herfarth C; Klar E
    Am J Surg; 1995 Jan; 169(1):161-6. PubMed ID: 7529462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of microcirculatory perfusion on distribution of trypsinogen activation peptides in acute experimental pancreatitis.
    Foitzik T; Hotz HG; Schmidt J; Klar E; Warshaw AL; Buhr HJ
    Dig Dis Sci; 1995 Oct; 40(10):2184-8. PubMed ID: 7587786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous contrast medium accentuates the severity of acute necrotizing pancreatitis in the rat.
    Foitzik T; Bassi DG; Schmidt J; Lewandrowski KB; Fernandez-del Castillo C; Rattner DW; Warshaw AL
    Gastroenterology; 1994 Jan; 106(1):207-14. PubMed ID: 8276183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of bacterial infection of the pancreas and its relation to disease severity in a rodent model of acute necrotizing pancreatitis.
    Foitzik T; Mithöfer K; Ferraro MJ; Fernández-del Castillo C; Lewandrowski KB; Rattner DW; Warshaw AL
    Ann Surg; 1994 Aug; 220(2):193-8. PubMed ID: 8053741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizing pancreatitis in rats.
    Hartwig W; Jimenez RE; Werner J; Lewandrowski KB; Warshaw AL; Fernández-del Castillo C
    Gastroenterology; 1999 Sep; 117(3):717-25. PubMed ID: 10464149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial protease activation is the central event in progression to necrotizing pancreatitis.
    Fernández-del Castillo C; Schmidt J; Warshaw AL; Rattner DW
    Surgery; 1994 Sep; 116(3):497-504. PubMed ID: 8079180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of impaired microcirculation and tissue oxygenation by hemodilution with hydroxyethyl starch plus cell-free hemoglobin in acute porcine pancreatitis.
    Freitag M; Standl TG; Kleinhans H; Gottschalk A; Mann O; Rempf C; Bachmann K; Gocht A; Petri S; Izbicki JR; Strate T
    Pancreatology; 2006; 6(3):232-9. PubMed ID: 16534248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Dextran 40 and aprotinin on experimental acute pancreatitis.
    Crocket KV; Reising JR; Wirman JA; Gau N; Joffe SN
    J Surg Res; 1984 Mar; 36(3):256-64. PubMed ID: 6199589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of platelet-activating factor antagonist WEB 2086 on microcirculatory disorders in acute experimental pancreatitis of graded severity.
    Mann O; Tiefenbacher WJ; Kaifi J; Schneider C; Kluth D; Bloechle C; Yekebas E; Izbicki JR; Strate T
    Pancreas; 2009 Jan; 38(1):58-64. PubMed ID: 18695628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premature trypsinogen activation during cerulein pancreatitis in rats occurs inside pancreatic acinar cells.
    Lüthen R; Owen RL; Sarbia M; Grendell JH; Niederau C
    Pancreas; 1998 Jul; 17(1):38-43. PubMed ID: 9667518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aprotinin revisited: formulation, characterization, biodistribution and therapeutic potential of new aprotinin microemulsion in acute pancreatitis.
    Karasulu HY; Oruç N; Üstündağ-Okur N; İlem Özdemir D; Ay Şenyiğit Z; Barbet Yılmaz F; Aşıkoğlu M; Özkılıç H; Akçiçek E; Güneri T; Özütemiz Ö
    J Drug Target; 2015; 23(6):525-37. PubMed ID: 25738992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A better model of acute pancreatitis for evaluating therapy.
    Schmidt J; Rattner DW; Lewandrowski K; Compton CC; Mandavilli U; Knoefel WT; Warshaw AL
    Ann Surg; 1992 Jan; 215(1):44-56. PubMed ID: 1731649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous contrast medium impairs oxygenation of the pancreas in acute necrotizing pancreatitis in the rat.
    Foitzik T; Bassi DG; Fernández-del Castillo C; Warshaw AL; Rattner DW
    Arch Surg; 1994 Jul; 129(7):706-11. PubMed ID: 8024450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous contrast medium aggravates the impairment of pancreatic microcirculation in necrotizing pancreatitis in the rat.
    Schmidt J; Hotz HG; Foitzik T; Ryschich E; Buhr HJ; Warshaw AL; Herfarth C; Klar E
    Ann Surg; 1995 Mar; 221(3):257-64. PubMed ID: 7717779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different immunosuppressive agents on acute pancreatitis: a comparative study in an improved animal model.
    Foitzik T; Forgacs B; Ryschich E; Hotz H; Gebhardt MM; Buhr HJ; Klar E
    Transplantation; 1998 Apr; 65(8):1030-6. PubMed ID: 9583861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of trypsinogen in experimental models of acute pancreatitis in rats.
    Nakae Y; Naruse S; Kitagawa M; Hirao S; Yamamoto R; Hayakawa T
    Pancreas; 1995 Apr; 10(3):306-13. PubMed ID: 7542773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis.
    Hirano T; Manabe T; Tobe T
    Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.